Oculocerebrocutaneous syndrome
Oculocerebrocutaneous syndrome (OCCS) is a rare congenital disorder characterized by anomalies affecting the eyes, brain, and skin. It is also known as Delleman-Oorthuys syndrome, named after the physicians who first described it.
Clinical Features[edit | edit source]
Oculocerebrocutaneous syndrome presents with a variety of clinical features, which can vary significantly among affected individuals. The primary features include:
- Ocular anomalies: These may include microphthalmia (abnormally small eyes), anophthalmia (absence of one or both eyes), coloboma (a defect in the eye structure), and cataracts.
- Neurological anomalies: These can include brain malformations, seizures, developmental delay, and intellectual disability.
- Cutaneous anomalies: Skin abnormalities such as skin tags, dermal cysts, and hypopigmented or hyperpigmented patches.
Etiology[edit | edit source]
The exact cause of Oculocerebrocutaneous syndrome is not well understood. It is believed to be a sporadic condition, meaning it typically occurs in individuals with no family history of the disorder. Genetic mutations are suspected to play a role, but no specific gene has been definitively linked to OCCS.
Diagnosis[edit | edit source]
Diagnosis of Oculocerebrocutaneous syndrome is primarily based on clinical findings. A thorough physical examination, including detailed ophthalmologic and neurological assessments, is essential. Imaging studies such as MRI or CT scan of the brain may be used to identify structural abnormalities. Genetic testing may be considered to rule out other conditions with similar presentations.
Management[edit | edit source]
There is no cure for Oculocerebrocutaneous syndrome, and treatment is symptomatic and supportive. Management may involve a multidisciplinary team including:
- Ophthalmologists for eye-related issues
- Neurologists for managing seizures and other neurological symptoms
- Dermatologists for skin anomalies
- Developmental pediatricians and therapists for developmental support
Prognosis[edit | edit source]
The prognosis for individuals with Oculocerebrocutaneous syndrome varies depending on the severity of the anomalies and the presence of associated complications. Early intervention and supportive care can improve the quality of life for affected individuals.
Related Pages[edit | edit source]
- Microphthalmia
- Anophthalmia
- Coloboma
- Cataracts
- Brain malformations
- Seizures
- Developmental delay
- Intellectual disability
- Skin tags
- Dermal cysts
- Hypopigmentation
- Hyperpigmentation
See Also[edit | edit source]
References[edit | edit source]
Template:Congenital malformations and deformations of the nervous system
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD